‹
›
This content requires a premium subscription.
Please
log in
or
subscribe
to continue.
JAMA Oncology Author Interviews
Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia
30
00:00:00
/ 00:15:19
30